FDA Approves Use of Two Anti-Malaria Drugs for Coronavirus
As the number of people who have fallen ill grows, the FDA announced approval if the use of two anti-malaria drugs for coronavirus.
As the number of people who have fallen ill grows, the FDA announced approval if the use of two anti-malaria drugs for coronavirus.
This page is a collection of information for our patients on COVID-19 and the coronavirus crisis of 2020 some of which was written by the LRG for patient support and some authored by outside authorities and curated by the LRG.
The Coronavirus outbreak has affected everyone across the globe in so many ways. In times like these, we must to continue to support each other as our mission to help enhance the survival and quality of life for GIST patients intensifies. Partner with us today by donating to support the continuation of this mission.
Lost in the relentless coverage of the COVD-19 pandemic are the many cancer patients trying to survive and needing to access quality medical care. Our gratitude goes out to all those physicians that have gone above and beyond to serve our GIST patients during this time.
Nuestro colaborador global, Alianza GIST comparte el artículo "El tratamiento de pacientes con cáncer y la contención de COVID-19: experiencias de Italia "por el Dr. Giuseppe Curigliano publicado en el ASCO Daily News. Este artículo también está disponible en inglés.
In this critical time, the FDA Oncology Center of Excellence wants you to know that we are here for patients with cancer and their health care providers and we will do everything we can to help you through the coronavirus crisis.
During this webcast presentation, Dr. Michael Heinrich will discuss these two new treatment options for advanced GIST. Dr. Heinrich will explain how each of these drugs works to target mutations for which there has previously been no targeted treatment and discuss the current coronavirus outbreak.
Dr. Breelyn Wilky, Director of Sarcoma Translational Research at the University of Colorado Cancer Center shares about Cancer vs. Coronavirus in her latest blog post covering hospital visits, keeping appointment scans, and risk factors for GIST patients.
These are trying times for everyone. As we move into uncharted territory created by the coronavirus pandemic, it is normal for the average person to experience fearful thoughts. Add to the mix fears that are ever present for those with a cancer diagnosis and you have a formula for anxiety.
The Life Raft Group is facing the same challenges we all are in light of this health crisis. We are doing our best on a daily basis to do the right thing in all matters impacting the well-being of our patients, caregivers, staff and everyone we serve.